Market Overview

UPDATE: Jefferies & Company Reiterates Buy Rating, Raises PT on Varian Medical Systems

Share:
Related VAR
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Results, Earnings And IPOs
MedTech's Long-Term Prospects Outweigh Near-Term Risks

In a report published Friday, Jefferies & Company reiterated its Buy rating on Varian Medical Systems (NYSE: VAR), and raised its price target from $65.00 to $68.00.

Jefferies noted, “VAR posted a strong F4Q with beats in revenues, EPS, and orders. Initial F13 guidance calls for 8-9% top-line growth. The strong surge in orders and higher outlook should ease persistent concerns of pressures from potential CMS reimbursement cuts, pricing, and competition.”

Varian Medical Systems closed on Thursday at $58.10.

Latest Ratings for VAR

DateFirmActionFromTo
Jun 2018JP MorganReinstatesNeutralUnderweight
Jan 2018JP MorganMaintainsNeutralNeutral
Jan 2018CitigroupMaintainsNeutralBuy

View More Analyst Ratings for VAR
View the Latest Analyst Ratings

Posted-In: Jefferies & CompanyAnalyst Color Price Target Analyst Ratings

 

Related Articles (VAR)

View Comments and Join the Discussion!